←
Peter Van Loo49 posts
Peter Van Loo avatar

Peter Van Loo

@VanLooLab

Professor in cancer genomics and tumor evolution at MD Anderson Cancer Center Visiting Group Leader at the Francis Crick Institute

◷ Joined March 2019▧ 1 Photos and videos
Peter Van Loo avatar
Peter Van Loo@VanLooLab·18 Dec 2023

Exciting find in our #OralCancer study! 🧬 Brush biopsies prove promising, reflecting 90% of somatic changes vs. tissue biopsies. 🩸 Highlighting their potential in understanding tumor evolution. #CancerEvolution biorxiv.org/content/10.1101/…

Peter Van Loo avatar
Peter Van Loo@VanLooLab·25 Oct 2023

📢Our latest preprint! We present GRITIC, a generic method to time complex copy number gains from WGS data. We apply GRITIC to 5656 tumors to paint the landscape of complex CNA evolution pan-cancer, focussing on genome-doubled primaries and mets. biorxiv.org/content/10.1101/…

Khandan Keyomarsi avatar
⟳ Peter Van Loo retweeted
Khandan Keyomarsi@kandymarsy·17 Nov 2022

World class TRIUMPH mentors are hiring post-doctoral fellows @MDAndersonNews: @JenWargoMD @swatowic @rkalluriMDPhD @TaniguchiMD @VanLooLab @tcellsrus @WenyiWang4 @AnilSoodMD @MazurLab @LiMaCancerLab @ACKoongMDPhD @skopetz @GeorgeACalin1 Apply: https://t.co/YeFVh5O0dm

The TRIUMPH program is hiring post-doctoral fellows @MDAndersonNews. Competitive compensation (~30% > NRSA). Mentors:@JimAllisonPhD @PamSharmaMDPhD @Aiims1742 @nicholas_navin @DraettaG @RonDePinho @lab_rezvani ⁩Apply: https://t.co/YeFVh5O0dm

Peter Van Loo avatar
Peter Van Loo@VanLooLab·22 Jun 2022

These signatures are the first step in cataloguing the processes that culminate in the copy number states we observe in tumors. As with mutational signatures, these studies have set a foundation for the community to build on their methods and discover CIN aetiologies. (4/4)

Peter Van Loo avatar
Peter Van Loo@VanLooLab·22 Jun 2022

@cd_steele et al. investigated allele-specific copy number signatures across human cancers. Copy number profiles from 9,873 cancers in TCGA were decomposed to reveal 21 signatures, many with a clear mechanistic origin: nature.com/articles/s41586-0… (2/4)

Peter Van Loo avatar
Peter Van Loo@VanLooLab·22 Jun 2022

For years, we’ve looked for recurrent copy number changes in cancer but lacked a pan-cancer view of the processes that give rise to these events. We've collaborated on two @Nature studies into the mechanisms underlying aneuploidy and chromosomal instability (1/4)

Peter Van Loo avatar
Peter Van Loo@VanLooLab·20 Jun 2022

Total mRNA expression in tumor cells is an important, but so far elusive, biomarker. This elegant piece of team science establishes the mathematical relationships between copy number, purity and gene expression in tumor cells. Proud to have been part of this great team!

Very excited to share our paper in Nature Biotechnology today! Huge amount of work by @ShaolongCao @sxj307 @JenniferWangMD et al! It is amazing to work with many experts across cancers. Every cancer tells its own story and our metric TmS can quantify it! go.nature.com/3mn0CAr

Peter Van Loo avatar
Peter Van Loo@VanLooLab·28 Apr 2022

Tumor samples vary in purity and ploidy, both of which confound DNA methylation measures from bulk sequencing. We developed CAMDAC to clean up this signal. Here's our extended preprint with new insights from applying CAMDAC to TRACERx lung RRBS data: biorxiv.org/content/10.1101/…

Peter Van Loo avatar
Peter Van Loo@VanLooLab·21 Apr 2022

Fantastic work linking somatic mutation rates with lifespan across mammalian species, allowing us to make sense of the lack of relationship between body size and cancer incidence.

Incredibly excited to share our paper ‘Somatic mutation rates scale with lifespan across mammals’ now published @nature. nature.com/articles/s41586-0… An illustrated & updated tweetorial… [1/24]

Post attachment